DR. LAURENS CLAEYS - NEFROLOGIE
0766.816.474 · rovalta.com · 26/09/2026
DR. LAURENS CLAEYS - NEFROLOGIE
Financial year 2026 · Closed on 30/04/2026
Overview
Identity
Source · BCE/KBODR. LAURENS CLAEYS - NEFROLOGIE is a Private limited company incorporated in 2021. Its registered office is in Sint-Martens-Latem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0766.816.474
- Incorporation
- 16/04/2021
- Legal form
- Private limited company
- Registered office
- Voordelaan 24
9831 Sint-Martens-Latem · FlandreSee on map - Contributed capital
- 100,00 €
- Latest accounts
- 30/04/2026
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2026 | 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 423,4 k € | +133% | 181,5 k € | +204% | 59,7 k € | -4.6% | 62,6 k € | -47.8% | 120 k € |
| EBITDA | 422,5 k € | +138% | 177,2 k € | +204% | 58,3 k € | -5.3% | 61,6 k € | -48.2% | 119 k € |
| Operating result | 394,9 k € | +150% | 157,7 k € | +214% | 50,2 k € | -11.5% | 56,7 k € | -50.2% | 114 k € |
| Net result | 299,5 k € | +150% | 119,7 k € | +206% | 39,1 k € | -11.6% | 44,3 k € | -50.4% | 89,3 k € |
| Balance sheet | |||||||||
| Equity | 100 € | -98.0% | 5,1 k € | -97.0% | 172,8 k € | +29.3% | 133,6 k € | +49.5% | 89,4 k € |
| Total assets | 364,4 k € | +66.6% | 218,7 k € | +19.4% | 183,1 k € | +29.7% | 141,2 k € | +9.6% | 128,8 k € |
| Cash | 122,5 k € | +88.4% | 65 k € | +7.4% | 60,5 k € | +8.6% | 55,7 k € | -11.8% | 63,1 k € |
| Debts | 364,3 k € | +70.6% | 213,6 k € | +2194% | 9,3 k € | +23.0% | 7,6 k € | -80.5% | 38,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/04/20261 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/05/2025 | 01/05/2024 | 01/05/2023 | 01/05/2022 | 16/04/2021 |
| Closing of the financial year | 30/04/2026 | 30/04/2025 | 30/04/2024 | 30/04/2023 | 30/04/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 13 months |
| Filing date | 22/06/2026 | 31/10/2025 | 26/11/2024 | 30/11/2023 | 30/11/2022 |
| General meeting | 16/06/2026 | 03/10/2025 | 04/10/2024 | 06/10/2023 | 07/10/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/04/20261 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2026Annual accounts 2026299,5 k €↑
- 2025Annual accounts 2025119,7 k €↑
- 2025Name changeDr. Laurens Claeyes- Nefrologie
- 2024Annual accounts 202439,1 k €↓
- 2023Annual accounts 202344,3 k €↓
- 2022Annual accounts 202289,3 k €
- 2022Name changeDR. LAURENS CLAEYS - NEFROLOGIE
- 16/04/2021IncorporationPrivate limited company